Hyaluronan - Regulator and initiator of peritoneal inflammation and remodeling

International Journal of Artificial Organs

Volumn 30, Issue 6, 2007, Pages 477-483

  Yung, Susan ^a,b   Chan, T M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Epithelial to mesenchymal transdifferentiation; Hyaluronan; Hyaluronan synthase; Inflammation; Microvilli; Peritoneum

Indexed keywords

HYALURONIC ACID;

EMBRYONIC DEVELOPMENT; EPITHELIAL-TO- MESENCHYMAL TRANSDIFFERENTIATION; HYALURONAN; HYALURONAN SYNTHASES; MICROVILLI; PERITONEAL DIALYSIS; PERITONEUM; PHENOTYPIC CHANGES; SIMPLE STRUCTURES; TRANSDIFFERENTIATION;

PATHOLOGY;

GROWTH FACTOR; HYALURONIC ACID;

ABRASION; ANGIOGENESIS; BLOOD LEVEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; DIALYSATE LEVEL; DISEASE MARKER; EMBRYO DEVELOPMENT; GLYCOCALYX; HUMAN; INFECTION; INFLAMMATION; MESENCHYME CELL; MESOTHELIUM CELL; METASTASIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEUM; PERITONITIS; PHENOTYPE; PREDICTION; REVIEW; SURFACE PROPERTY; SURVIVAL; TISSUE INJURY; TISSUE REPAIR; WOUND HEALING;

EID: 34547872802     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000605     Document Type: Review

References (58)

1. Gokal R. Long term peritoneal dialysis - is it a reality? J Nephrol 1999; 12: 362-70.
2. Di Paolo N, Sacchi G, De Mia M, et al. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 204-11.
3. Honda K, Nitta K, Horita S, et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 1999; 14: 1541-9.
4. Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-9.
5. Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int 2003; 64 (suppl 88): S43-9.
6. Yung S, Coles GA, Williams JD, Davies M. The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 1994; 46: 527-33.
7. Spicer AP, Kaback LA, Smith TJ, Seldin ME Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes. J Biol Chem 1998; 273: 25117-24.
8. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem 1997; 272: 13997-4000.
9. Itano N, Sawai T, Yoshida M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999; 274: 25085-92.
10. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992; 6: 2397-404.
11. Slevin M, Krupinski J, Gaffney J, et al. Hyaluronan-mediated angiogenesis in vascular disease: Uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 2007; 26: 58-68.
12. Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: Host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 2006; 20: 9-22.
13. Toole BP, Zoltan-Jones A, Misra S, Ghatak S. Hyaluronan: A critical component of epithelial-mesenchymal and epithelial-carcinoma transitions. Cells Tissue Organs 2005; 179: 66-72.
14. Roth J. Ultrahistochemical demonstration of saccharide components of complex carbohydrates at the alveolar cell surface and at the mesothelial cell surface of the pleura visceralis of mice by means of Concanavalin A. Exp Pathol (Jena) 1973; 8: 157-67.
15. Mutsaers SE. Mesothelial cells: Their structure, function and role in serosal repair. Respirology 2002; 7: 171-91.
16. Mutsaers SE, Whitaker D, Papadimitriou JM. Changes in the concentration of microvilli on the free surface of healing mesothelium are associated with alterations in surface membrane charge. J Pathol 1996; 180: 333-9.
17. Kultti A, Rilla K, Tiihonen R, Spicer AP, Tammi RH, Tammi MI. Hyaluronan synthesis induces microvillus-like cell surface protrusions. J Biol Chem 2006; 281: 15821-8.
18. Brosius FC, Heilig CW. Glucose transporters in diabetic nephropathy. Pediatr Nephrol 2005; 20: 447-51.
19. Lange K. Role of microvillar cell surfaces in the regulation of glucose uptake and organization of energy metabolism. Am J Physiol Cell Physiol 2002; 282: C1-26.
20. Schroppel B, Fischereder M, Wiese P, et al. Expression of glucose transporters in human peritoneal mesothelial cells. Kidney Int 1998; 53: 1278-87.
21. Fischereder M, Schroppel B, Wiese P, et al. Regulation of glucose transporters in human peritoneal mesothelial cells. J Nephrol 2003; 16: 103-9.
22. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001; 7: 213-21.
23. Day AJ, de la Motte CA. Hyaluronan cross-linking: A protective mechanism in inflammation? Trends Immunol 2005; 26: 637-43.
24. Teder P, Vandivier RW, Jiang D, et al. Resolution of lung inflammation by CD44. Science 2002; 296: 155-8.
25. Rees MD, Hawkins CL, Davies MJ. Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-acetyl glycosamines: Evidence for chloramide intermediates, free radical transfer reactions, and site-specific fragmentation. J Am Chem Soc 2003; 125: 13719-33.
26. Soltes L, Mendichi R, Kogan G, Schiller J, Stankovska M, Arnhold J. Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules 2006; 7: 659-68.
27. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: An information-rich system. Eur J Cell Biol 2006; 85: 699-715.
28. McKee CM, Penno MB, Cowman M, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996; 98: 2403-13.
29. McKee CM, Lowenstein CJ, Horton MR, et al. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism. J Biol Chem 1997; 272: 8013-8.
30. Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005; 11: 1173-9.
31. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002; 21: 25-9.
32. Hodge-Dufour J, Marino MW, Horton MR, et al. Inhibition of interferon gamma induced interleukin 12 production: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci U S A 1998; 95: 13806-11.
33. Szeto CC, Wong TY, Lai KB, Lam CW, Lai KN, Li PK. Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 36: 609-14.
34. Yung S, Coles GA, Davies M. IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: Relevance to peritonitis in CAPD. Kidney Int 1996; 50: 1337-43.
35. Breborowicz A, Pyda M, Moberly J, Martis L, Oreopoulos D. Effect of hyaluronan-supplemented dialysate on in vitro function of human peritoneal mesothelial cells. Am J Nephrol 2004; 24: 316-21.
36. Breborowicz A, Wisniewska J, Polubinska A, Wieczorowska-Tobis K, Martis L, Oreopoulos DG. Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis. Perit Dial Int 1998; 18: 382-6.
37. Lai KN, Szeto CC, Lai KB, Lam CW, Chan DT, Leung JC. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD. Am J Kidney Dis 1999; 33: 318-24.
38. Yung S, Thomas GJ, Davies M. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int 2000; 58: 1953-62.
39. Horiuchi T, Miyamoto K, Miyamoto S, et al. Image analysis of remesothelialization following chemical wounding of cultured human peritoneal mesothelial cells: The role of hyaluronan synthesis. Kidney Int 2003; 64: 2280-90.
40. Haslinger B, Mandl-Weber S, Sellmayer A, Sitter T. Hyaluronan fragments induce the synthesis of MCP-1 and IL-8 in cultured human peritoneal mesothelial cells. Cell Tissue Res 2001; 305: 79-86.
41. Yung S, Li FK, Chan TM. Peritoneal mesothelial cell culture and biology. Perit Dial Int 2006; 26: 162-73.
42. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-13.
43. Zoltan-Jones A, Huang L, Ghatak S, Toole BP. Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem 2003; 278: 45801-10.
44. Jenkins RH, Thomas GJ, Williams JD, Steadman R. Myofibroblastic differentiation leads to hyaluronan accumulation through reduced hyaluronan turnover. J Biol Chem 2004; 279: 41453-60.
45. Martin J, Yung S, Robson RL, Steadman R, Davies M. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Perit Dial Int 2000; 20: 524-33.
46. Fukudome K, Fujimoto S, Sato Y, Hisanaga S, Eto T. Peritonitis increases MMP-9 activity in peritoneal effluent from CAPD patients. Nephron 2001; 87: 35-41.
47. Rougier JP, Guia S, Hagege J, Nguyen G, Ronco PM. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: Transcriptional regulation by TGF-beta 1. Kidney Int 1998; 54: 87-98.
48. Fieber C, Baumann P, Vallon R, et al. Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J Cell Sci 2004; 117: 359-67.
49. Alaniz L, Garcia M, Cabrera P, et al. Modulation of matrix metalloproteinase-9 activity by hyaluronan is dependent on NF-kappaB activity in lymphoma cell lines with dissimilar invasive behavior. Biochem Biophys Res Commun 2004; 324: 736-43.
50. Polubinska A, Pawlaczyk K, Kuzlan-Pawlaczyk M, et al. Dialysis solution containing hyaluronan: Effect on peritoneal permeability and inflammation in rats. Kidney Int 2000; 57: 1182-9.
51. Wang T, Cheng HH, Heimburger O, et al. Hyaluronan decreases peritoneal fluid absorption: Effect of molecular weight and concentration of hyaluronan. Kidney Int 1999; 55: 667-73.
52. Wang T, Chen C, Heimburger O, Waniewski J, Bergstrom J, Lindholm B. Hyaluronan decreases peritoneal fluid absorption in peritoneal dialysis. J Am Soc Nephrol 1997; 8: 1915-20.
53. Breborowicz A, Kuzlan-Pawlaczyk M, Wieczorowska-Tobis K, et al. The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts. Adv Perit Dial 1998; 14: 31-5.
54. Brebarowicz A, Polubinska A, Wu G, Tam P, Oreopoulos DG. N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats. Blood Purif 2006; 24: 274-81.
55. Breborowicz A, Polubinska A, Simon M, Tam P, Wu G, N-Acetylglucosamine- an osmotic slute for peritoneal dialysis without inducing hyperinsulinemia. Blood Purif 2004; 22: 183-7.
56. Breborowicz A, Pawlaczyk-Kuzlan M, Pawlaczyk K, Baum E, Tam P, Wu G. Replacement of glucose with N-acetylglucosamine in peritoneal dialysis fluid-experimental study in rats. Perit Dial Int 2001; 21 (suppl 3): S365-7.
57. Wu G, Wieczorowska-Tobis K, Polubinska A, et al. N-acetylglucosamine changes permeability of peritoneum during chronic peritoneal dialysis in rats. Perit Dial Int 1998; 18: 217-24.
58. Flessner MF, Choi J, Vanpelt H, et al. Correlating structure with solute and water transport in a chronic model of peritoneal inflammation. Am J Physiol Renal Physiol 2006; 290: F232-40.